Myriad Genetics Inc
NASDAQ:MYGN

Watchlist Manager
Myriad Genetics Inc Logo
Myriad Genetics Inc
NASDAQ:MYGN
Watchlist
Price: 3.91 USD -0.51%
Market Cap: 360.4m USD

Wall Street
Price Targets

MYGN Price Targets Summary
Myriad Genetics Inc

Wall Street analysts forecast MYGN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MYGN is 15.33 USD with a low forecast of 8.08 USD and a high forecast of 30.45 USD.

Lowest
Price Target
8.08 USD
107% Upside
Average
Price Target
15.33 USD
292% Upside
Highest
Price Target
30.45 USD
679% Upside
Myriad Genetics Inc Competitors:
Price Targets
4597
Solasia Pharma KK
84% Upside
ZEAL
Zealand Pharma A/S
114% Upside
2696
Shanghai Henlius Biotech Inc
16% Downside
GNS
Genus PLC
22% Upside
MRNA
Moderna Inc
72% Upside
ADMA
ADMA Biologics Inc
31% Upside
IGMS
IGM Biosciences Inc
53% Upside
AGIO
Agios Pharmaceuticals Inc
85% Upside

Revenue
Forecast

Revenue Estimate
Myriad Genetics Inc

For the last 3 years the compound annual growth rate for Myriad Genetics Inc's revenue is 7%. The projected CAGR for the next 3 years is 4%.

7%
Past Growth
4%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Myriad Genetics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Myriad Genetics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MYGN's stock price target?
Price Target
15.33 USD

According to Wall Street analysts, the average 1-year price target for MYGN is 15.33 USD with a low forecast of 8.08 USD and a high forecast of 30.45 USD.

What is Myriad Genetics Inc's Revenue forecast?
Projected CAGR
4%

For the last 3 years the compound annual growth rate for Myriad Genetics Inc's revenue is 7%. The projected CAGR for the next 3 years is 4%.

Back to Top